BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 21880354)

  • 41. Distinctive blood eosinophilic phenotypes and cytokine patterns in eosinophilic esophagitis, inflammatory bowel disease and airway allergy.
    Johnsson M; Bove M; Bergquist H; Olsson M; Fornwall S; Hassel K; Wold AE; Wennerås C
    J Innate Immun; 2011; 3(6):594-604. PubMed ID: 21921589
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epithelial-stromal crosstalk and fibrosis in eosinophilic esophagitis.
    Muir AB; Wang JX; Nakagawa H
    J Gastroenterol; 2019 Jan; 54(1):10-18. PubMed ID: 30101408
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Loss of Endothelial TSPAN12 Promotes Fibrostenotic Eosinophilic Esophagitis via Endothelial Cell-Fibroblast Crosstalk.
    Shoda T; Wen T; Caldwell JM; Ben-Baruch Morgenstern N; Osswald GA; Rochman M; Mack LE; Felton JM; Abonia JP; Arva NC; Atkins D; Bonis PA; Capocelli KE; Collins MH; Dellon ES; Falk GW; Gonsalves N; Gupta SK; Hirano I; Leung J; Menard-Katcher PA; Mukkada VA; Putnam PE; Rudman Spergel AK; Spergel JM; Wechsler JB; Yang GY; Aceves SS; Furuta GT; Rothenberg ME;
    Gastroenterology; 2022 Feb; 162(2):439-453. PubMed ID: 34687736
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.
    Masuyama K; Jacobson MR; Rak S; Meng Q; Sudderick RM; Kay AB; Lowhagen O; Hamid Q; Durham SR
    Immunology; 1994 Jun; 82(2):192-9. PubMed ID: 7927488
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antifibrotic Effects of the Thiazolidinediones in Eosinophilic Esophagitis Pathologic Remodeling: A Preclinical Evaluation.
    Nhu QM; Hsieh L; Dohil L; Dohil R; Newbury RO; Kurten R; Moawad FJ; Aceves SS
    Clin Transl Gastroenterol; 2020 Apr; 11(4):e00164. PubMed ID: 32352681
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Eosinophilic Esophagitis-Associated Chemical and Mechanical Microenvironment Shapes Esophageal Fibroblast Behavior.
    Muir AB; Dods K; Henry SJ; Benitez AJ; Lee D; Whelan KA; DeMarshall M; Hammer DA; Falk G; Wells RG; Spergel J; Nakagawa H; Wang ML
    J Pediatr Gastroenterol Nutr; 2016 Aug; 63(2):200-9. PubMed ID: 26727658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fluticasone propionate improves quality of life in patients with asthma requiring oral corticosteroids.
    Okamoto LJ; Noonan M; DeBoisblanc BP; Kellerman DJ
    Ann Allergy Asthma Immunol; 1996 May; 76(5):455-61. PubMed ID: 8630720
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparisons of Fluticasone to Budesonide in the Treatment of Eosinophilic Esophagitis.
    Albert D; Heifert TA; Min SB; Maydonovitch CL; Baker TP; Chen YJ; Moawad FJ
    Dig Dis Sci; 2016 Jul; 61(7):1996-2001. PubMed ID: 27093866
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Active eosinophilic esophagitis is characterized by epithelial barrier defects and eosinophil extracellular trap formation.
    Simon D; Radonjic-Hösli S; Straumann A; Yousefi S; Simon HU
    Allergy; 2015 Apr; 70(4):443-52. PubMed ID: 25620273
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Conservative long-term treatment of children with eosinophilic esophagitis.
    Levine J; Lai J; Edelman M; Schuval SJ
    Ann Allergy Asthma Immunol; 2012 May; 108(5):363-6. PubMed ID: 22541409
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The esophageal biopsy "pull" sign: a highly specific and treatment-responsive endoscopic finding in eosinophilic esophagitis (with video).
    Dellon ES; Gebhart JH; Higgins LL; Hathorn KE; Woosley JT; Shaheen NJ
    Gastrointest Endosc; 2016 Jan; 83(1):92-100. PubMed ID: 26142556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of sphingosine 1-phosphate receptor expression in eosinophils of patients with allergic rhinitis, and effect of topical nasal steroid treatment on this receptor expression.
    Mackle T; Gendy SS; Walsh M; McConn-Walsh R; Costello RW; Walsh MT
    J Laryngol Otol; 2008 Dec; 122(12):1309-17. PubMed ID: 18808729
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of correlation between the process of thyroid fibrosis and TGFB1 gene expression level in fine-needle aspiration biopsy (FNAB) thyroid specimens collected from patients with Hashimoto's thyroiditis and non-toxic goitre.
    Cyniak-Magierska A; Januszkiewicz-Caulier J; Brzeziańska E; Lewiński A
    Exp Clin Endocrinol Diabetes; 2010 Jul; 118(7):420-6. PubMed ID: 20191437
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis.
    Peterson KA; Thomas KL; Hilden K; Emerson LL; Wills JC; Fang JC
    Dig Dis Sci; 2010 May; 55(5):1313-9. PubMed ID: 19533356
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased incidence of eosinophilic esophagitis in children and adults with celiac disease.
    Thompson JS; Lebwohl B; Reilly NR; Talley NJ; Bhagat G; Green PH
    J Clin Gastroenterol; 2012 Jan; 46(1):e6-e11. PubMed ID: 21778897
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The accuracy of endoscopic features in eosinophilic esophagitis: the experience in children from rural West Virginia.
    Al-Subu A; Bevins L; Yulia D; Elitsur Y
    J Clin Gastroenterol; 2012; 46(10):e83-6. PubMed ID: 23060222
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Control of inflammation decreases the need for subsequent esophageal dilation in patients with eosinophilic esophagitis.
    Runge TM; Eluri S; Woosley JT; Shaheen NJ; Dellon ES
    Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 29206905
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral delivery of fluticasone powder improves esophageal eosinophilic inflammation and symptoms in adults with eosinophilic esophagitis.
    Kia L; Nelson M; Zalewski A; Gregory D; Gonsalves N; Straumann A; Hirano I
    Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 30380044
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adult versus pediatric eosinophilic esophagitis: important differences and similarities for the clinician to understand.
    Lucendo AJ; Sánchez-Cazalilla M
    Expert Rev Clin Immunol; 2012 Nov; 8(8):733-45. PubMed ID: 23167685
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alterations in junctional proteins, inflammatory mediators and extracellular matrix molecules in eosinophilic esophagitis.
    Abdulnour-Nakhoul SM; Al-Tawil Y; Gyftopoulos AA; Brown KL; Hansen M; Butcher KF; Eidelwein AP; Noel RA; Rabon E; Posta A; Nakhoul NL
    Clin Immunol; 2013 Aug; 148(2):265-78. PubMed ID: 23792687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.